Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Amerigo Scientific Highlights Cell-Free Expression Supplies with pEU Vector Set

    Jan 2, 2024, 09:12 AM by
    Full story
  • BOC Sciences and Spaya Join Forces to Expand Chemical Offerings

    Jan 2, 2024, 09:06 AM by
    BOC Sciences, a leading chemical supplier, has partnered with Spaya, an AI-powered chemical synthesis platform, to enhance the portfolio of commercially available materials by listing an unprecedented 140,000+ chemical products.
    Full story
  • Andelyn Biosciences Selected by Ultragenyx for Late-Stage Process Performance Qualification (PPQ) Manufacturing of Novel Gene Therapy for Sanfilippo Syndrome

    Jan 2, 2024, 09:06 AM by
    Columbus, OH, December 18, 2023 - Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), announced that it has been selected by Ultragenyx (NASDAQ: RARE) to perform late-stage Process Performance Qualification (PPQ) manufacturing of the company’s UX111 gene therapy for the potential treatment of Sanfilippo Syndrome (MPS IIIA).
    Full story
  • Genomenon Launches Classification Service, Medidata’s New Research Alliance, New Devices, Platforms, More

    Dec 28, 2023, 01:00 AM by User Not Found
    Bio-IT World | Genomenon launched Genomenon Curate-Pro variant classification service; Medidata launches the Medidata Research Alliance; Edinburgh Innovations has announced a novel 3D printed device that could replace the need for drug and chemical safety testing on animals; and more.
    Full story
  • Follow the Money: AI For Drug Discovery, Small Molecule Therapeutics, Multi-Omics Platform for Women’s Reproductive Immunotherapies, More

    Dec 27, 2023, 01:00 AM by User Not Found
    Bio-IT World | Sanofi enters a multi-year research collaboration with French pharmatech company Aqemia; Apple Tree Partners will expand its portfolio company Deep Apple Therapeutics to rapidly discover novel small molecule therapeutics for high-value targets through virtual screening of AI-generated virtual libraries; Freya Biosciences intends to advance their multi-omics data science platform; and more.
    Full story
  • ‘Reverse Metabolomics’ Enables Biological Discoveries From Repository Data

    Dec 21, 2023, 01:00 AM by User Not Found
    Bio-IT World | In a turnaround of the usual metabolomics study approach, University of California San Diego scientists are homing in on the microbial-produced molecules that interact with cells and affect human health. A couple million such molecules are likely awaiting discovery in this fashion.
    Full story
  • Terran Biosciences Receives FDA Clearance for NM-101, the Industry’s First Software for the Analysis of Neuromelanin-sensitive MRI

    Dec 20, 2023, 09:15 AM by
    Terran Biosciences Receives FDA Clearance for NM-101, the Industry’s First Software for the Analysis of Neuromelanin-sensitive MRI
    Full story
  • Alfa Chemistry Unveils Its Cosmetic and Personal Care Product Testing Capabilities

    Dec 20, 2023, 09:15 AM by
    Full story
  • AppOmni Unveils First AI SaaS Security Posture Management Assistant, AskOmni, Redefining SaaS Security and Usability

    Dec 20, 2023, 09:15 AM by
    AppOmni, SaaS Security Posture Management (SSPM) leader and SaaS security pioneer, today unveiled a groundbreaking advancement with the introduction of AskOmni. This first AI-powered SSPM assistant developed by the AppOmni OmniScience team propels SSPM into new dimensions, simplifying security operations and issue remediation, and helping organizations secure mission-critical SaaS environments.
    Full story
  • Stability Analysis Plays a Crucial Role in Pharmaceutical Formulation, Highlighted by CD Formulation

    Dec 20, 2023, 09:15 AM by
    Full story
  • Abzena partners with FDA on publication demonstrating the benefits of the MAPPs assay for immunogenicity

    Dec 20, 2023, 09:15 AM by
    Abzena, a leading CDMO for biologics, collaborates with the FDA on a publication endorsing the MHC Associated Peptide Proteomics (MAPPs) assay for assessing immunogenicity in drug development. The article underscores MAPPs' precision in identifying potential immunogenicity risks in early preclinical stages, reducing the likelihood of anti-drug antibodies (ADAs) and optimizing biologics. Abzena integrates MAPPs into its immunogenicity services, aiming to de-risk drug development. The Chief Scientific Officer, Dr. Campbell Bunce, emphasizes the assay's value in informing drug regions that may induce ADAs. The collaboration aims to expedite safer, more effective therapies for patients.
    Full story
  • Owkin enters collaboration agreement with MSD to develop AI-powered diagnostics for cancer

    Dec 20, 2023, 09:15 AM by
    Owkin, a French-American biotechnology company that applies artificial intelligence (AI) to drug discovery, development, and diagnostics, today announced that it has entered into a collaboration agreement with MSD, the trade name of Merck & Co Inc., Rahway NJ USA to develop and commercialize AI-powered digital pathology diagnostics for the EU market.
    Full story
  • NIH Program Tackles Bottlenecks In ‘Wild West’ Field Of exRNA Biology

    Dec 20, 2023, 01:00 AM by User Not Found
    Bio-IT World | Driven by advancements in technology and data accessibility, computational methods and artificial intelligence (AI) have seen remarkable growth this past decade. This surge has ushered in a new era of problem-solving across a plethora of industries and domains.
    Full story
  • PubHive Launches Enterprise Portal & Tailored Literature Workflow

    Dec 19, 2023, 09:29 AM by
    PubHive Navigator Enterprise Portal consolidates all workspaces, virtual libraries, folders, and internal content into one intuitive research platform, streamlining tailored research workflow and collaboration.
    Full story
  • Recipharm harmonizes its global quality operations with Veeva Vault Quality

    Dec 19, 2023, 09:29 AM by
    Hi Hope you are well and are having a great week so far! I just wanted to pass on the latest news from Recipharm, who has chosen Veeva Systems to streamline global quality operations. The move aims to enhance oversight, resource efficiency, validation speed, and inspection readiness. The full release is below. Thank you Charlotte
    Full story
  • Living Biobank Of Brain Metastasis Samples Enabling ‘Personalized Medicine 2.0’

    Dec 19, 2023, 01:00 AM by User Not Found
    Bio-IT World | Driven by advancements in technology and data accessibility, computational methods and artificial intelligence (AI) have seen remarkable growth this past decade. This surge has ushered in a new era of problem-solving across a plethora of industries and domains.
    Full story
  • Analyzing Delivery Systems: CD Formulation Introduces In Vitro Testing to Measure Microsphere and Microneedle Release

    Dec 18, 2023, 08:49 AM by
    Full story
  • Oz-UK Ltd announces new low-GWP manufacturing line installation to meet global need for pMDIs ahead of the Kigali Amendment deadline

    Dec 18, 2023, 08:49 AM by
    Oz-UK Ltd announces the installation of its new low-GWP (global warming potential) manufacturing line.
    Full story
  • PrecisionLife Project Awarded Innovate UK Grant to Improve Diagnosis and Treatment of ME/CFS and Long Covid

    Dec 18, 2023, 08:49 AM by
    Leading computational biology company PrecisionLife®, which is driving precision medicine in complex chronic diseases, the ME/CFS charity Action for M.E., and the MRC Human Genetics Unit at the Institute of Genetics and Cancer, University of Edinburgh have been awarded a £622,000 grant by Innovate UK's Advancing Precision Medicine programme to improve diagnosis and treatment for the millions of people affected by ME/CFS and long Covid.
    Full story
  • X-Chem Announces Achievement of Collaboration Milestone

    Dec 18, 2023, 08:49 AM by
    Full story
  • «
  • 51
  • 52
  • 53 (current)
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy